Financial Architects (New Jersey)’s Ironwood Pharmaceuticals IRWD Stock Holding History

Financial Architects (New Jersey)’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,791	Closed	-$16K	–	1469
2018 Q4	$16K	Sell	1,791 -1,791	-50%	-$20.6K	﹤0.01%	865
2018 Q3	$56K	Buy	+3,582	New	+$56.6K	0.01%	599
2018 Q2	–	Sell	-1,194	Closed	-$15K	–	1411
2018 Q1	$15K	Buy	+1,194	New	+$14.9K	﹤0.01%	966

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

Financial Architects (New Jersey)'s IRWD Position: Q1 2019 in Review

Financial Architects (New Jersey) sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2019, closing a stake of 597 shares — an estimated $5K sold.

Financial Architects (New Jersey) first reported a position in IRWD in Q3 2016 and held it in 7 quarters. The position peaked at $19K in Q2 2017. 156 funds tracked by Wall St. Rank hold IRWD as of Q1 2019.

Financial Architects (New Jersey) reported no remaining Ironwood Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
Financial Architects (New Jersey) sold 597 Ironwood Pharmaceuticals shares in Q1 2019, an estimated $5K.
Financial Architects (New Jersey) first reported a position in Ironwood Pharmaceuticals in Q3 2016 and held it in 7 quarters.
Financial Architects (New Jersey)'s Ironwood Pharmaceuticals position peaked at $19K in Q2 2017.
156 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q1 2019, filed 3 May 2019.